Free Trial

Alpha Cognition (ACOG) Competitors

Alpha Cognition logo
$8.35 +0.19 (+2.33%)
As of 03:59 PM Eastern

ACOG vs. ALMS, KOD, BCYC, UPXI, EOLS, TECX, ARCT, PRME, ETON, and PRTC

Should you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Alumis (ALMS), Kodiak Sciences (KOD), Bicycle Therapeutics (BCYC), Upexi (UPXI), Evolus (EOLS), Tectonic Therapeutic (TECX), Arcturus Therapeutics (ARCT), Prime Medicine (PRME), Eton Pharmaceuticals (ETON), and PureTech Health (PRTC). These companies are all part of the "pharmaceutical products" industry.

Alpha Cognition vs. Its Competitors

Alumis (NASDAQ:ALMS) and Alpha Cognition (NASDAQ:ACOG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

Alpha Cognition's return on equity of -80.16% beat Alumis' return on equity.

Company Net Margins Return on Equity Return on Assets
AlumisN/A -119.15% -92.50%
Alpha Cognition N/A -80.16%-60.95%

Alpha Cognition has lower revenue, but higher earnings than Alumis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alumis$20.06M23.87-$294.23MN/AN/A
Alpha CognitionN/AN/A-$14.64M-$1.60-5.22

In the previous week, Alumis and Alumis both had 2 articles in the media. Alpha Cognition's average media sentiment score of 1.39 beat Alumis' score of 0.38 indicating that Alpha Cognition is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alumis
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Cognition
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alumis has a beta of -1.38, meaning that its share price is 238% less volatile than the S&P 500. Comparatively, Alpha Cognition has a beta of 2.71, meaning that its share price is 171% more volatile than the S&P 500.

Alumis presently has a consensus target price of $20.17, indicating a potential upside of 338.41%. Alpha Cognition has a consensus target price of $20.00, indicating a potential upside of 139.52%. Given Alumis' stronger consensus rating and higher probable upside, equities research analysts clearly believe Alumis is more favorable than Alpha Cognition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alumis
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
Alpha Cognition
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Alumis and Alpha Cognition tied by winning 5 of the 10 factors compared between the two stocks.

Get Alpha Cognition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACOG vs. The Competition

MetricAlpha CognitionMED IndustryMedical SectorNASDAQ Exchange
Market Cap$134.94M$3.12B$5.76B$9.91B
Dividend YieldN/A2.28%6.66%4.49%
P/E Ratio-5.2221.0283.0126.65
Price / SalesN/A379.56503.03163.66
Price / CashN/A43.5325.7028.92
Price / Book3.228.1210.796.52
Net Income-$14.64M-$53.35M$3.29B$266.21M
7 Day Performance3.60%0.05%0.02%-0.76%
1 Month Performance-4.46%7.08%7.06%3.83%
1 Year PerformanceN/A11.92%50.09%24.39%

Alpha Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACOG
Alpha Cognition
2.517 of 5 stars
$8.35
+2.3%
$20.00
+139.5%
N/A$134.94MN/A-5.22N/A
ALMS
Alumis
2.5714 of 5 stars
$4.74
-3.3%
$20.17
+325.5%
-61.6%$492.74M$20.06M0.00N/A
KOD
Kodiak Sciences
3.8097 of 5 stars
$9.24
-2.4%
$11.75
+27.2%
+254.1%$491.77MN/A-2.4590
BCYC
Bicycle Therapeutics
2.9431 of 5 stars
$6.99
-1.8%
$22.22
+218.0%
-65.9%$481.70M$35.28M-1.98240Positive News
UPXI
Upexi
2.1986 of 5 stars
$8.28
+8.9%
$15.50
+87.3%
+59.5%$480.02M$26M0.00130Gap Down
EOLS
Evolus
4.5294 of 5 stars
$7.40
-0.5%
$21.25
+187.3%
-52.6%$479.60M$266.27M-7.57170News Coverage
Positive News
Short Interest ↓
TECX
Tectonic Therapeutic
2.2755 of 5 stars
$25.48
+3.7%
$80.33
+215.3%
-14.9%$476.73MN/A-6.31120News Coverage
Positive News
Analyst Forecast
ARCT
Arcturus Therapeutics
3.6463 of 5 stars
$17.44
-1.5%
$50.57
+190.0%
-11.3%$476.44M$152.31M-7.87180News Coverage
Positive News
Analyst Forecast
PRME
Prime Medicine
3.5252 of 5 stars
$3.54
+0.4%
$8.92
+152.2%
-13.5%$475.72M$4.96M-1.72234Positive News
ETON
Eton Pharmaceuticals
2.5725 of 5 stars
$17.27
+1.1%
$29.67
+71.8%
+279.3%$463.05M$39.01M-107.9120News Coverage
Positive News
PRTC
PureTech Health
2.3561 of 5 stars
$19.11
+0.6%
$45.00
+135.5%
-24.8%$461.00M$4.83M0.00100Short Interest ↑
Gap Down

Related Companies and Tools


This page (NASDAQ:ACOG) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners